Sexual medicine reviews最新文献

筛选
英文 中文
Investigating iontophoresis as a therapeutic approach for Peyronie's disease: a systematic review. 将离子透入疗法作为佩罗尼氏病治疗方法的研究:系统综述。
IF 3.6 2区 医学
Sexual medicine reviews Pub Date : 2025-01-31 DOI: 10.1093/sxmrev/qeae058
Sahand Eslami, Fateme Tahmasbi, Alireza Rahimi-Mamaghani, Sarvin Sanaie, Carlo Bettocchi, Omid Sedigh, Farzin Soleimanzadeh
{"title":"Investigating iontophoresis as a therapeutic approach for Peyronie's disease: a systematic review.","authors":"Sahand Eslami, Fateme Tahmasbi, Alireza Rahimi-Mamaghani, Sarvin Sanaie, Carlo Bettocchi, Omid Sedigh, Farzin Soleimanzadeh","doi":"10.1093/sxmrev/qeae058","DOIUrl":"10.1093/sxmrev/qeae058","url":null,"abstract":"<p><strong>Introduction: </strong>Iontophoresis therapy (IPT) is a noninvasive technique that uses electrical impulses to deliver charged molecules into the skin for controlled and targeted drug delivery. IPT has been explored as a noninvasive treatment option for Peyronie's disease (PD), but the current literature in this regard is still scarce.</p><p><strong>Objective: </strong>We aimed to systematically review the current literature on the application of IPT in the management of PD to provide a comprehensive evaluation and holistic outlook on the subject.</p><p><strong>Method: </strong>A comprehensive search strategy was implemented in the following databases to retrieve research articles: PubMed (MEDLINE), Scopus, and Web of Science. Google Scholar was also manually searched. The search results were imported into Rayyan reference management for assessment based on the predefined inclusion criteria. The quality of the articles was evaluated by the proper JBI checklist (ie, per the study design), and the JBI grades of recommendation were used for grading the evidence.</p><p><strong>Results: </strong>A systematic search yielded 451 publications, 11 of which met the criteria to be included in this systematic review. The results demonstrated that IPT, usually with verapamil and dexamethasone, has shown promising results in treating PD. These methods can reduce pain, plaque size, and penile curvature while improving sexual function and quality of life with no serious adverse events. However, most studies had moderate to low quality, indicating a weak recommendation for a certain health management strategy.</p><p><strong>Conclusion: </strong>Based on the extant literature, there is currently insufficient evidence to support the use of IPT for the management of PD. Placing it in the forefront of research can facilitate the management choices for PD even further, given its therapeutic potential.</p>","PeriodicalId":21813,"journal":{"name":"Sexual medicine reviews","volume":" ","pages":"41-51"},"PeriodicalIF":3.6,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142073899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erectile dysfunction as a holistic indicator of well-being: a narrative review. 勃起功能障碍作为幸福感的综合指标:叙述性综述。
IF 3.6 2区 医学
Sexual medicine reviews Pub Date : 2025-01-31 DOI: 10.1093/sxmrev/qeae066
Gal Saffati, Zheyar Seyan, Daniela Orozco Rendon, Mana Almuhaideb, David E Hinojosa-Gonzalez, Shane Kronstedt, Mohit Khera
{"title":"Erectile dysfunction as a holistic indicator of well-being: a narrative review.","authors":"Gal Saffati, Zheyar Seyan, Daniela Orozco Rendon, Mana Almuhaideb, David E Hinojosa-Gonzalez, Shane Kronstedt, Mohit Khera","doi":"10.1093/sxmrev/qeae066","DOIUrl":"10.1093/sxmrev/qeae066","url":null,"abstract":"<p><strong>Introduction: </strong>Erectile dysfunction (ED), affecting around 52% of men aged 40-70, is a significant marker of overall health and a potential warning sign of multiple conditions like cardiovascular diseases (CVDs), diabetes, and mental health disorders. Recognizing and addressing ED through a holistic approach involving nutrition, physical activity, sleep, and stress management can improve both erectile and overall health outcomes.</p><p><strong>Aims: </strong>To provide a narrative review of the available literature on the relationship between ED and overall health, elaborate on the possible mechanisms explaining this association, and discuss the effects of lifestyle on ED.</p><p><strong>Methods: </strong>A search of the medical literature was carried out in PubMed and Medline, focusing on original research and systematic reviews of original research on ED and overall health.</p><p><strong>Results: </strong>Due to shared pathophysiological mechanisms like endothelial dysfunction, ED is a significant indicator of overall health, particularly related to CVD and diabetes mellitus. Multiple studies have shown that ED frequently precedes cardiovascular events and is associated with increased cardiovascular risk, especially in younger men and those with diabetes. It also has a profound, bidirectional relationship with mental health conditions like depression and anxiety, creating a vicious cycle where each exacerbates the other. The four health pillars of nutrition, physical activity, sleep, and stress management play significant roles in erectile function and overall sexual health.</p><p><strong>Conclusion: </strong>ED is not just a condition affecting sexual function but a critical indicator of broader health issues. By adopting an integrative approach that combines nutrition, physical activity, sleep, and stress management, healthcare providers can offer holistic and effective management strategies for this condition.</p>","PeriodicalId":21813,"journal":{"name":"Sexual medicine reviews","volume":" ","pages":"11-19"},"PeriodicalIF":3.6,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142376041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Newer formulations of oral testosterone undecanoate: development and liver side effects. 较新的十一酸睾酮口服制剂:开发和肝脏副作用。
IF 3.6 2区 医学
Sexual medicine reviews Pub Date : 2025-01-31 DOI: 10.1093/sxmrev/qeae062
Irwin Goldstein, Nachiappan Chidambaram, Adrian Dobs, Shelby King, Martin Miner, Ranjith Ramasamy, Faysal A Yafi, Mohit Khera
{"title":"Newer formulations of oral testosterone undecanoate: development and liver side effects.","authors":"Irwin Goldstein, Nachiappan Chidambaram, Adrian Dobs, Shelby King, Martin Miner, Ranjith Ramasamy, Faysal A Yafi, Mohit Khera","doi":"10.1093/sxmrev/qeae062","DOIUrl":"10.1093/sxmrev/qeae062","url":null,"abstract":"<p><strong>Introduction: </strong>Testosterone deficiency is a clinical disorder due to either failure of the testes to produce testosterone or failure of the hypothalamus or pituitary to produce sufficient gonadotropins. Previous formulations of oral testosterone therapy, particularly methyltestosterone, have been associated with adverse liver effects. Many different routes of testosterone delivery have been developed, each with their own administrative benefits and challenges. Newer formulations of oral testosterone undecanoate (TU) provide a convenient administration option, although their use has been limited by hepatotoxicity concerns based on older methyltestosterone data, and prescribing physicians may still be concerned about adverse liver effects.</p><p><strong>Objectives: </strong>In this review, we discuss the history of oral testosterone development, clarify the mechanism of action of oral TU, and describe the relevant liver safety findings.</p><p><strong>Methods: </strong>Relevant literature was allocated to present a review on the history of oral TU development and the mechanism of action of oral TU. We pooled data from individual studies of oral TU products to present a safety summary.</p><p><strong>Results: </strong>Overall, safety results from studies of the newer formulations of oral TU showed that increased liver function test values are not generally associated with oral TU formulations and that no clinically significant liver toxicities were noted in clinical trials of oral TU.</p><p><strong>Conclusion: </strong>Continued research into the safety of oral TU will contribute to a better understanding of the potential risks in patients receiving this therapy, an outcome that highlights the importance of providing patient education and reassurance regarding oral TU safety.</p>","PeriodicalId":21813,"journal":{"name":"Sexual medicine reviews","volume":" ","pages":"33-40"},"PeriodicalIF":3.6,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142295935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is sexual function impaired in patients with primary headaches? A systematic review of observational studies. 原发性头痛患者的性功能是否受损?观察性研究的系统回顾。
IF 3.6 2区 医学
Sexual medicine reviews Pub Date : 2025-01-31 DOI: 10.1093/sxmrev/qeae064
Kübra Ataş, Ebru Kaya Mutlu
{"title":"Is sexual function impaired in patients with primary headaches? A systematic review of observational studies.","authors":"Kübra Ataş, Ebru Kaya Mutlu","doi":"10.1093/sxmrev/qeae064","DOIUrl":"10.1093/sxmrev/qeae064","url":null,"abstract":"<p><strong>Introduction: </strong>Primary headaches, particularly migraine and tension-type headaches, as chronic and painful conditions, have a significant impact on individuals' health and overall quality of life, including aspects such as sexual health parameters.</p><p><strong>Objectives: </strong>The aim of this study was to review observational studies and to summarize the presence of sexual dysfunction in patients with primary headache and to discern whether it is more common in patients with primary headache than in healthy control subjects.</p><p><strong>Methods: </strong>Observational studies published between January 1, 2000, and May 21, 2023 were searched in Medline (PubMed), Web of Science, Scopus, and EBSCO. This review included 23 observational studies that evaluated sexual dysfunction with or without comparison with healthy control subjects.</p><p><strong>Results: </strong>As a result, the mean Female Sexual Function Index score, a score of <26.55 indicating sexual dysfunction, ranged from 19.25 ± 8.18 to 27.5 ± 7.5 in patients with primary headache. The prevalence of sexual dysfunction and erectile dysfunction was found to be between 10.7% and 93.75% in female patients and between 54.83% and 80% in male patients. Both migraineurs and tension-type headache sufferers had statistically significantly lower sexual function scores in females and lower erectile function scores in males compared with healthy control subjects.</p><p><strong>Conclusion: </strong>Sexual function is significantly affected in patients with primary headache, which is a chronic painful disorder. Therefore, it is very important to ask these patients about their sexual health and, if necessary, to seek support from a sexual health professional. Additionally, future studies may prioritize tension-type headaches and male patients due to the limited amount of research available on these subjects.</p>","PeriodicalId":21813,"journal":{"name":"Sexual medicine reviews","volume":" ","pages":"94-104"},"PeriodicalIF":3.6,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142393450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: Newer formulations of oral testosterone undecanoate: development and liver side effects.
IF 3.6 2区 医学
Sexual medicine reviews Pub Date : 2025-01-31 DOI: 10.1093/sxmrev/qeaf007
{"title":"Correction to: Newer formulations of oral testosterone undecanoate: development and liver side effects.","authors":"","doi":"10.1093/sxmrev/qeaf007","DOIUrl":"10.1093/sxmrev/qeaf007","url":null,"abstract":"","PeriodicalId":21813,"journal":{"name":"Sexual medicine reviews","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143067998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comprehensive summary of eponymous awards and scholarships in sexual medicine. 性医学同名奖项和奖学金的全面汇总。
IF 3.6 2区 医学
Sexual medicine reviews Pub Date : 2025-01-31 DOI: 10.1093/sxmrev/qeae069
Thomas A Alvermann, Christopher C Robertson, James M Jones, Martin S Gross
{"title":"A comprehensive summary of eponymous awards and scholarships in sexual medicine.","authors":"Thomas A Alvermann, Christopher C Robertson, James M Jones, Martin S Gross","doi":"10.1093/sxmrev/qeae069","DOIUrl":"10.1093/sxmrev/qeae069","url":null,"abstract":"<p><strong>Introduction: </strong>Numerous eponymous awards and scholarships exist within sexual medicine. This comprehensive review is intended to summarize these awards and highlight the esteemed sexual medicine experts for whom these awards are named.</p><p><strong>Objectives: </strong>To provide historical background and context for the various eponymous awards in sexual medicine.</p><p><strong>Methods: </strong>The websites of the International Society for Sexual Medicine (ISSM) and the regional affiliate societies, including the Sexual Medicine Society of North America (SMSNA), International Society for the Study of Women's Sexual Health (ISSWSH), and various regional societies were identified, and all awards associated with a member of note were documented. In cases where no awards were identified within a regional society and a contact person was available, inquiries were made regarding the existence of awards. Several documents on the history of the ISSM were utilized for background on awards.</p><p><strong>Results: </strong>A comprehensive list of current awards and their history was compiled.</p><p><strong>Conclusion: </strong>This is the first comprehensive history of eponymous awards and scholarships available in sexual medicine.</p>","PeriodicalId":21813,"journal":{"name":"Sexual medicine reviews","volume":" ","pages":"3-10"},"PeriodicalIF":3.6,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142508336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychological and interpersonal dimensions of sexual function and dysfunction: recommendations from the fifth international consultation on sexual medicine (ICSM 2024). 性功能和功能障碍的心理和人际层面:第五届性医学国际咨询会议(ICSM 2024)的建议。
IF 3.6 2区 医学
Sexual medicine reviews Pub Date : 2024-12-30 DOI: 10.1093/sxmrev/qeae073
Lori A Brotto, Sandrine Atallah, Joana Carvalho, Elisabeth Gordon, Patrícia M Pascoal, Mona Reda, Kyle R Stephenson, Inês M Tavares
{"title":"Psychological and interpersonal dimensions of sexual function and dysfunction: recommendations from the fifth international consultation on sexual medicine (ICSM 2024).","authors":"Lori A Brotto, Sandrine Atallah, Joana Carvalho, Elisabeth Gordon, Patrícia M Pascoal, Mona Reda, Kyle R Stephenson, Inês M Tavares","doi":"10.1093/sxmrev/qeae073","DOIUrl":"https://doi.org/10.1093/sxmrev/qeae073","url":null,"abstract":"<p><strong>Introduction: </strong>Sexual health concerns are common and significantly impact quality of life, but many people do not seek treatment due to embarrassment and other barriers. A biopsychosocial model of assessment and treatment acknowledges the biological, psychological, and social contributors to sexual difficulties and suggests that all these domains should be evaluated.</p><p><strong>Objectives: </strong>This paper provides an overview of the major psychological factors contributing to sexual difficulties and offer an evidence-based approach for primary care clinicians to assess and treat these issues.</p><p><strong>Methods: </strong>A comprehensive literature review was undertaken focusing on articles published since the last consultation in 2016. The study findings were synthesized, critiqued, authors assigned a Grading of Recommendation as Weak or Strong following a year-long process of discussions among the committee. When a particular well-established psychological practice was not evaluated in the literature, we assigned an expert opinion recommendation.</p><p><strong>Results: </strong>Since the 2015 ICSM, there have been a number of high-quality trials of psychological treatments addressing sexual dysfunctions, as well as meta-analyses and systematic reviews. In some domains, there is strong evidence of psychological treatment, and primary care providers should be aware of such approaches and refer when appropriate.</p><p><strong>Conclusions: </strong>This paper offers a practical guide for primary care clinicians to understand the psychological factors underlying sexual dysfunction and outlining what approaches may be appropriate for this clinician, and when the patient should be referred to a specialist. We emphasize an evidence-based approach to managing sexual dysfunctions in primary care, allowing for timely interventions. A comprehensive evaluation of biopsychosocial factors is recommended to personalize psychological interventions to overall context, including chronic diseases, mental health issues, and relationship conflicts. The initial assessment is key to developing an individualized intervention plan, which may include psychoeducation, referral for cognitive-behavioral therapy, mindfulness, or couple therapy, and consideration of medical or digital health interventions.</p>","PeriodicalId":21813,"journal":{"name":"Sexual medicine reviews","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142955348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diabetes mellitus and female sexual response: what do animal models tell us? 糖尿病与女性性反应:动物模型能告诉我们什么?
IF 3.6 2区 医学
Sexual medicine reviews Pub Date : 2024-09-25 DOI: 10.1093/sxmrev/qeae044
Abigail Karina Hernández-Munive, Mildred Berenice Molina-Leonor, Brenda Denisse Ayala-González, Joanna Vázquez-Andrade, Alberto Medina-Nieto, Alonso Fernández-Guasti
{"title":"Diabetes mellitus and female sexual response: what do animal models tell us?","authors":"Abigail Karina Hernández-Munive, Mildred Berenice Molina-Leonor, Brenda Denisse Ayala-González, Joanna Vázquez-Andrade, Alberto Medina-Nieto, Alonso Fernández-Guasti","doi":"10.1093/sxmrev/qeae044","DOIUrl":"10.1093/sxmrev/qeae044","url":null,"abstract":"<p><strong>Background: </strong>One of the less explored effects of diabetes mellitus (DM) is female sexual dysfunction. Females of different species have been used as models.</p><p><strong>Aim: </strong>To analyze the information of animal models of DM and female sexual response (FSR).</p><p><strong>Methods: </strong>The literature of FSR in models of DM was reviewed.</p><p><strong>Outcomes: </strong>Paradigm- and diabetes-dependent changes have been found in various aspects of the FSR.</p><p><strong>Results: </strong>Females in a type 1 DM (DM1) model show a decrease in the number of proestrus events, and ovariectomized females treated with sex hormones have been used. In these females, a reduction in lordosis has been reported; in proceptivity, the data are contradictory. These females present a decrease in sexual motivation that was restored after exogenous insulin. In the type 2 DM (DM2) model, females show regular estrous cycles, normal levels of lordosis behavior, and, depending on the paradigm, decreased proceptivity. These females display normal preference for sexually active males or their olfactory cues when having free physical contact; they lose this preference when tested in paradigms where physical interaction is precluded.</p><p><strong>Clinical translation: </strong>Preclinical data showing the high deleterious effects of a DM1 model and the less drastic effects under a DM2 model are in accordance with clinical data revealing a much higher prevalence of sexual dysfunction in women with DM1 than DM2.</p><p><strong>Strengths and limitations: </strong>The main strength is the analysis of the changes in various components of FSR in 2 models of DM. The main limitation is the difficulty in extrapolating the data on FSR from rats to women and that most studies focus on evaluating the impact of severe or chronic-moderate hyperglycemia/hyperinsulinemia on the sexual response, without considering other pathophysiologic alterations generated by DM.</p><p><strong>Conclusion: </strong>Females with severe hyperglycemia have a decrease in FSR, while those with moderate hyperglycemia show much less drastic effects.</p>","PeriodicalId":21813,"journal":{"name":"Sexual medicine reviews","volume":" ","pages":"542-550"},"PeriodicalIF":3.6,"publicationDate":"2024-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141327888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of gynecologic cancer on female sexuality in Europe and MENA (Middle East and North Africa): a literature review. 妇科癌症对欧洲和中东及北非女性性行为的影响:文献综述。
IF 3.6 2区 医学
Sexual medicine reviews Pub Date : 2024-09-25 DOI: 10.1093/sxmrev/qeae039
Malihe Shams, Claudia Coman, Fabiola Fatone, Vittoria Marenesi, Roberto Bernorio, Alessandra Feltrin, Elena Groff
{"title":"The impact of gynecologic cancer on female sexuality in Europe and MENA (Middle East and North Africa): a literature review.","authors":"Malihe Shams, Claudia Coman, Fabiola Fatone, Vittoria Marenesi, Roberto Bernorio, Alessandra Feltrin, Elena Groff","doi":"10.1093/sxmrev/qeae039","DOIUrl":"10.1093/sxmrev/qeae039","url":null,"abstract":"<p><strong>Introduction: </strong>Gynecologic cancer has a negative impact on the sexuality of women who are or have been affected by this disease. In fact, gynecologic cancers cause negative changes in female sexuality, affecting body image and psychophysical well-being, with serious consequences for women's sex lives.</p><p><strong>Objectives: </strong>The aim of this study is to analyze the differences in sexuality among women who have or have had gynecologic cancer in Europe and in the Middle East and North Africa (MENA). We also explored possible factors that may influence women's sexuality in the 2 populations compared.</p><p><strong>Methods: </strong>The literature search was carried out using PubMed and Google Scholar, considering the 10-year period of 2013 to 2023. Studies were initially selected according to the criterion that the title and abstract were in English. We then reviewed all the articles selected in the first phase and analyzed the following information: author, year of publication, type of gynecologic cancer, country in which the study was conducted, design, and materials used. Finally, we defined the inclusion criteria for the present paper: women 18 years of age or older, diagnosed with gynecologic cancer, and who had undergone treatment (surgery, chemotherapy, radiotherapy). The studies reviewed were conducted between 2013 and 2023 in Europe and MENA, and all analyzed sexual function after the disease, understood as a general dimension that includes physiological and psychological aspects.</p><p><strong>Results: </strong>The results of this research show that patients in both geographical areas (Europe and MENA) report changes in sexuality as a result of the cancer. Studies show that cancer reduces, interrupts, and impairs women's sexual activity, resulting in experiences of discomfort, anxiety, guilt, inadequacy, pain, and poorer quality of life.</p><p><strong>Conclusions: </strong>The data analyzed in this review show that cancer causes changes and deterioration in sexuality in both populations studied. No cultural or social factors were found to cause differences between the variables studied in the 2 populations. In the future, it may be interesting to carry out further studies to improve the treatment of women with gynecologic cancer, as sexuality is a very important part of a person's life.</p>","PeriodicalId":21813,"journal":{"name":"Sexual medicine reviews","volume":" ","pages":"587-599"},"PeriodicalIF":3.6,"publicationDate":"2024-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141293722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling the science behind erectile dysfunction topical therapy: investigating transdermal papaverine as a novel treatment approach. 揭开勃起功能障碍局部疗法背后的科学面纱:将透皮罂粟碱作为一种新型治疗方法进行研究。
IF 3.6 2区 医学
Sexual medicine reviews Pub Date : 2024-09-25 DOI: 10.1093/sxmrev/qeae059
Hojjat Rezaiezadeh, Marziyeh Ranjbar Tavakoli, Mohammad Amin Langarizadeh, Zahra Saeedi Garaghani, Somayyeh Karami-Mohajeri
{"title":"Unveiling the science behind erectile dysfunction topical therapy: investigating transdermal papaverine as a novel treatment approach.","authors":"Hojjat Rezaiezadeh, Marziyeh Ranjbar Tavakoli, Mohammad Amin Langarizadeh, Zahra Saeedi Garaghani, Somayyeh Karami-Mohajeri","doi":"10.1093/sxmrev/qeae059","DOIUrl":"10.1093/sxmrev/qeae059","url":null,"abstract":"<p><strong>Introduction: </strong>Erectile dysfunction is among the most prevalent urologic issues affecting men globally and is characterized by a high incidence rate. This condition significantly affects the quality of life of patients and their sexual partners.</p><p><strong>Objectives: </strong>Due to the interactions, contraindications, and side effects associated with systemic drugs, recent research has increasingly focused on topical and transdermal medications for the treatment of erectile dysfunction.</p><p><strong>Methods: </strong>Based on previous studies, this article examines papaverine in terms of local effectiveness, methods of increasing therapeutic efficiency, possible local side effects, and evaluation of its various formulations.</p><p><strong>Results: </strong>Among these approaches, notable strategies include using novel formulations and nanoformulations as compared with classic ones, employing permeation enhancers, and combining treatments with other oral and topical drugs with synergistic mechanisms. These methods aim to improve transdermal papaverine's bioavailability and therapeutic efficacy while minimizing side effects and enhancing patient compliance.</p><p><strong>Conclusion: </strong>Transdermal papaverine may not be as effective as its injectable form, but the treatment path is more pleasant, with less pain and fewer side effects for patients. For this reason, using solutions that remove the penile skin and fascial absorption barrier can be very effective.</p>","PeriodicalId":21813,"journal":{"name":"Sexual medicine reviews","volume":" ","pages":"720-730"},"PeriodicalIF":3.6,"publicationDate":"2024-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142037009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信